Picture of Bio Plus Co logo

099430 Bio Plus Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Annual cashflow statement for Bio Plus Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line9,70310,67320,70827,42217,510
Depreciation
Amortisation
Non-Cash Items3,9208,2745,4782,6036,543
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-4,590-6,892-14,713-16,475-5,033
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities10,04313,35213,35916,04022,290
Capital Expenditures-1,096-15,358-6,694-21,572-96,647
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-481-7,277-60,43643,30112,283
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-1,577-22,634-67,13021,728-84,364
Financing Cash Flow Items-2,376-15-3,940-350
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities4,82734,04530,659-10,21253,719
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash13,14625,035-22,67727,653-7,331